Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axis.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axis.
Kim E, Shohet J. Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axis. J Natl Cancer Inst. 2009 Nov 18; 101(22):1527-9.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Cyclin-Dependent Kinase Inhibitor p16
Humans
Imidazoles
Mice
Mice, Transgenic
Neuroblastoma
N-Myc Proto-Oncogene Protein
Nuclear Proteins
Oncogene Proteins
Piperazines
Proto-Oncogene Proteins c-mdm2
Transcriptional Activation
Tumor Suppressor Protein p53
authors with profiles
Jason Matthew Shohet MD, PhD